PRESS RELEASE published on 01/10/2024 at 22:30, 2 years 5 months ago CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results Catheter Precision, Inc. (VTAK:NYSE/American), a US-based medical device company, announced unaudited preliminary annual and fourth quarter results of 2023. These results included total revenues, cash on hand, total assets, shareholders equity, and preliminary net loss. The company also highlighted key achievements of the year, including sales and clinical personnel onboarding and training, product launches, study enrollments, and intellectual property expansion. CEO David Jenkins expressed optimism for 2024, emphasizing the momentum and market potential of their products. The company cautioned that the results are subject to finalization, internal review, potential adjustments, and external audit, with consideration for potential impact from impairment analysis and future royalties. For more information, please refer to the original press release on accesswire.com. Financial Results Catheter Precision 2024 Outlook Medical Device David Jenkins
PRESS RELEASE published on 01/03/2024 at 14:00, 2 years 6 months ago Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors Catheter Precision, a US-based medical device company, has announced changes to its executive management and board of directors, including the appointment of Margrit Thomassen as the interim Chief Financial Officer and the naming of David Jenkins as the Chief Executive Officer. The company, focused on electrophysiology products, aims to continue its growth and meet the needs of patients, hospitals, and physicians. The announcement also includes the resignation of Susanne Meline from the Board of Directors and the appointment of John Francis as her replacement. These changes are part of the company's strategic plan for the upcoming year. Electrophysiology Products Medical Device Company Catheter Precision Executive Management Interim Chief Financial Officer
PRESS RELEASE published on 01/02/2024 at 14:00, 2 years 6 months ago Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market Catheter Precision, Inc. announced the allowance of two new patents (No. 6288592 and No. 015023977-0001) in Great Britain and the European Market for its LockeT product line, further solidifying the company's IP position. These patents demonstrate the company's commitment to the uniqueness of the closure product design, strengthening its global presence in the electrophysiology products market. Catheter Precision Inc. LockeT Patents Electrophysiology Products Medical Device Company Great Britain And European Market
PRESS RELEASE published on 12/22/2023 at 14:00, 2 years 6 months ago Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
PRESS RELEASE published on 12/18/2023 at 14:00, 2 years 6 months ago CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 6 months ago Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023 Catheter Precision, Inc. (NYSE American:VTAK) to present its innovative non-invasive 3D mapping system, VIVO, at the Emerging Growth Conference on December 6, 2023. The event offers an opportunity for real-time interaction with the CEO Catheter Precision Inc. Medical Device Company VIVO Emerging Growth Conference 3D Mapping System
PRESS RELEASE published on 11/20/2023 at 14:00, 2 years 7 months ago Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
PRESS RELEASE published on 10/12/2023 at 14:00, 2 years 8 months ago Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
PRESS RELEASE published on 10/10/2023 at 14:00, 2 years 8 months ago Catheter Precision Showcasing its Innovative 3D Mapping System
PRESS RELEASE published on 09/07/2023 at 14:00, 2 years 9 months ago Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published on 07/03/2026 at 23:00, 1 day 10 hours ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 1 day 12 hours ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 1 day 14 hours ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 20 hours ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/04/2026 at 17:35, 15 hours 55 minutes ago Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 22 hours 29 minutes ago EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day ago Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 1 day 14 hours ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 1 day 14 hours ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 21:49, 1 day 11 hours ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 1 day 11 hours ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 1 day 14 hours ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 1 day 14 hours ago Disclosure of transactions in own shares from July 1 to July 3, 2026